# ClearPoint Neuro, Inc. (CLPT) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ClearPoint Neuro, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/CLPT/mda/fy2025/): filed 2026-03-17; accession 0001193125-26-111231 (https://www.sec.gov/Archives/edgar/data/1285550/000119312526111231/clpt-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/CLPT/mda/fy2024/): filed 2025-02-26; accession 0000950170-25-027934 (https://www.sec.gov/Archives/edgar/data/1285550/000095017025027934/clpt-20241231.htm)
- [FY 2023 MD&A](/company/CLPT/mda/fy2023/): filed 2024-03-12; accession 0001285550-24-000031 (https://www.sec.gov/Archives/edgar/data/1285550/000128555024000031/clpt-20231231.htm)
- [FY 2022 MD&A](/company/CLPT/mda/fy2022/): filed 2023-03-01; accession 0001285550-23-000020 (https://www.sec.gov/Archives/edgar/data/1285550/000128555023000020/clpt-20221231.htm)
- [FY 2021 MD&A](/company/CLPT/mda/fy2021/): filed 2022-03-09; accession 0001285550-22-000003 (https://www.sec.gov/Archives/edgar/data/1285550/000128555022000003/clpt-20211231.htm)

Back to /company/CLPT/